Notice of Additional Participation in PAR-16-052"Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21)"

Notice Number: NOT-TW-16-002

Key Dates
Release Date:   January 8, 2016

Related Announcements
PAR-16-052

Issued by
Fogarty International Center (FIC)
National Institute on Drug Abuse (NIDA)
National Institute on Aging (NIA)
Office of Behavioral and Social Sciences Research (OBSSR)

Purpose

This Notice is to inform potential applicants that additional NIH components will participate in PAR-16-052 and to detail additional interests of NIDA and NIA.

The following changes have been made to reflect the participation of NIA and OBSSR in this FOA and to detail the interests of NIDA and NIA.

Part 1. Overview Information

Components of Participating Organizations
Fogarty International Center (FIC)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
National Institute on Minority Health and Health Disparities (NIMHD)
Office of Dietary Supplements (ODS)
Office of Research on Women’s Health (ORWH)
National Institute on Aging (NIA)
Office of Behavioral and Social Sciences Research (OBSSR)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.989, 93.867; 93.279; 93.213; 93.321; 93.399; 93.396; 93.395; 93.394; 93.393; 93.313; 93.307; 93.866

 

Part 2. Section 1. Funding Opportunity Description

Specific Research Interests of the FOA Sponsors
The National Institute on Drug Abuse (NIDA)
Drug addiction impacts health and well-being far beyond the direct deleterious effects of drug exposure. Acute and chronic drug use and their sequelae, including unhealthy lifestyles, are related to non-communicable diseases and disorders such as cardiovascular disease, stroke, cancer, hepatitis, malnutrition, lung disease and others. Importantly, drug abuse is still an important driver of HIV/AIDS infection in parts of the world. Drugs of abuse also contribute to injury and trauma both as causes and in long-term consequences. Some of these effects occur when drugs are used at high doses or after prolonged use; however, some may occur after just one use. Research on how various drugs of abuse affect different parts of the body is encouraged and more information can be found at:  https://www.drugabuse.gov/related-topics/medical-consequences-drug-abuse  where links will take you to more information on: Cardiovascular Effects,  Respiratory Effects, Gastrointestinal Effects, Musculoskeletal Effects, Kidney Damage, Liver Damage, Hormonal Effects, Cancer, Prenatal Effects, Other Health Effects and Mortality.

The National Institute on Aging (NIA)

The National Institute on Aging (NIA) encourages research on those aging with multi-morbidity, the frail elderly, trajectories of healthy aging, and health and long-term care systems that help prevent and delay onset of disease and dysfunction: https://www.nia.nih.gov/research. Applicants seeking to use observational data for secondary analysis or cross-national comparative research can find a useful guide to NIA-funded resources at the Gateway to Global Aging Data: https://g2aging.org/.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

John Haaga, Ph.D
National Institute on Aging (NIA)
Telephone: 301-496-3131
Email: John.Haaga@nih.gov

Wendy Smith, Ph.D
Office of Behavioral & Social Sciences Research (OBSSR)
Telephone: 301-435-3718
Email: smithwe@mail.nih.gov

Financial/Grants Management Contacts

Linda Whipp
National Institute on Aging (NIA)
Telephone: 301-402-7731
Email: whippl@nia.nih.gov

All other aspects of the FOA (PAR-16-052) remain unchanged.

Inquiries

Please direct all inquiries to

Kathleen Michels, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-1653
Email: FIC-NCD@mail.nih.gov